ENS 54959: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
Line 10: | Line 10: | ||
| utype = | | utype = | ||
| cfr = 10 CFR 30.50(b)(4) | | cfr = 10 CFR 30.50(b)(4) | ||
| emergency class = | | emergency class = Non Emergency | ||
| notification date = 10/20/2020 18:05 | | notification date = 10/20/2020 18:05 | ||
| notification by = Matthew Trusner | | notification by = Matthew Trusner |
Latest revision as of 12:15, 15 January 2021
Where | |
---|---|
Curium Pharma Noblesville, Indiana (NRC Region 3) | |
License number: | 13-35179-03 |
Organization: | Curium Pharma |
Reporting | |
10 CFR 30.50(b)(4) | |
Time - Person (Reporting Time:+4.08 h0.17 days <br />0.0243 weeks <br />0.00559 months <br />) | |
Opened: | Matthew Trusner 18:05 Oct 20, 2020 |
NRC Officer: | Brian Lin |
Last Updated: | Oct 20, 2020 |
54959 - NRC Website | |